IPA (ImmunoPrecise Antibodies) Additional Paid-In Capital : $9.24 Mil(As of Oct. 2024)

View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Additional Paid-In Capital?

ImmunoPrecise Antibodies's quarterly additional paid-in capital increased from Apr. 2024 ($9.06 Mil) to Jul. 2024 ($9.15 Mil) and increased from Jul. 2024 ($9.15 Mil) to Oct. 2024 ($9.24 Mil).

ImmunoPrecise Antibodies's annual additional paid-in capital increased from Apr. 2022 ($7.63 Mil) to Apr. 2023 ($8.01 Mil) and increased from Apr. 2023 ($8.01 Mil) to Apr. 2024 ($9.06 Mil).

ImmunoPrecise Antibodies Additional Paid-In Capital Historical Data

The historical data trend for ImmunoPrecise Antibodies's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Additional Paid-In Capital Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Additional Paid-In Capital

Get a 7-Day Free Trial

2.69

5.76

7.63

8.01

9.06

ImmunoPrecise Antibodies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Additional Paid-In Capital	Get a 7-Day Free Trial															8.69	9.05	9.06	9.15	9.24

ImmunoPrecise Antibodies Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

ImmunoPrecise Antibodies Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

TQB:Germany TQB:Germany

Address

3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8

Website

https://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.